Friday, 16 October 2026European Markets

ORPEA Stock Impressive Slide 11% So Far On Monday, Underperforms Market

Loading stream...

(vianews) - shares of orpea (cac 40: orp.pa) fell by a staggering 11.13% to €2.27 at 14:07 est on monday, after three sequential sessions in a row of gains. cac 40 is sliding 0.5% to €7,351.67, following the last session's upward trend. this seems, at the moment, a somewhat bearish trend exchanging session today.

orpea's last close was €2.55, 90.3% under its 52-week high of €26.29.

about orpea

orpea sa operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. the company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. in addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. the company operates in france, belgium, spain, italy, ireland, switzerland, austria, germany, the czech republic, poland, the netherlands, luxembourg, portugal, brazil, russia, slovenia, uruguay, colombia, mexico, chile, latvia, croatia, and china. orpea sa was founded in 1989 and is headquartered in puteaux, france.

earnings per share

as for profitability, orpea has a trailing twelve months eps of €-66.14.

yearly top and bottom value

orpea's stock is valued at €2.27 at 14:07 est, way below its 52-week high of €26.29 and way above its 52-week low of €1.74.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, orpea's stock is considered to be oversold (<=20).

more news about orpea (orp.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com